Friday 15th February 2013 |
Text too small? |
Shares of APN News & Media were halted after the Irish Independent newspaper reported that 28.95 percent owner Independent News & Media has called for the resignation of chief executive and director Brett Chenoweth.
The report said INM had formally advised APN of its views and was seeking an extraordinary meeting of shareholders. INM had "lost confidence in Mr Chenoweth's ability to implement the strategic initiatives necessary to reposition APN for the more challenged media landscape that has emerged in Australasia," it said, citing an INM statement.
APN said today that Chenoweth and his strategy have the unanimous support of non-INM directors.
The dual-listed shares last traded 30 Australian cents on the ASX.
APN sought the trading halt "in light of press reports today regarding comments by Independent News & Media concerning APN's CEO," according to its statement to the ASX.
It was investigating the comments, which it believed stemmed from APN's consideration of a pro-rata capital raising, it said. The company is being advised by Macquarie Capital on the potential capital raising.
"The reason for the trading halt taking place is to prevent trading taking place in a speculative or uninformed market while APN investigates INM's comments and completes deliberations about a potential capital raising," it said.
The media company is grappling with falling advertising revenue and plans to sell non-core media assets in New Zealand following a strategic review of operations in this country. It took an A$485 million charge against its New Zealand publishing assets unit as part of the ongoing review.
New Zealand billionaire Owen Glenn last month told BusinessDesk he passed on a chance to bid for the NZ Herald, saying the numbers didn't stack up.
BusinessDesk.co.nz
No comments yet
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors
December 19th Morning Report